istradefylline and Retinal-Neovascularization

istradefylline has been researched along with Retinal-Neovascularization* in 1 studies

Other Studies

1 other study(ies) available for istradefylline and Retinal-Neovascularization

ArticleYear
Adenosine A
    Molecular medicine (Cambridge, Mass.), 2018, 07-31, Volume: 24, Issue:1

    Retinopathy of prematurity (ROP) remains a major cause of childhood blindness and current laser photocoagulation and anti-VEGF antibody treatments are associated with reduced peripheral vision and possible delayed development of retinal vasculatures and neurons. In this study, we advanced the translational potential of adenosine A. Developing C57BL/6 mice were exposed to 75% oxygen from postnatal (P) day 7 to P12 and to room air from P12 to P17 and treated with KW6002 or vehicle at different postnatal developmental stages. Retinal vascularization was examined by whole-mount fluorescence and cross-sectional hematoxylin-eosin staining. Cellular proliferation, astrocyte and microglial activation, and tip cell function were investigated by isolectin staining and immunohistochemistry. Apoptosis was analyzed by TUNEL assay. The effects of oxygen exposure and KW6002 treatment were analyzed by two-way ANOVA or Kruskal-Wallis test or independent Student's t-test or Mann-Whitney U test.. The A. As ROP being a biphasic disease, our identification of the hyperoxic phase as the effective window, together with selective and robust protection against pathological (but not physiological) angiogenesis, elevates A

    Topics: Adenosine A2 Receptor Antagonists; Animals; Hyperoxia; Mice, Inbred C57BL; Purines; Retinal Neovascularization; Retinopathy of Prematurity

2018